<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16466">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01693809</url>
  </required_header>
  <id_info>
    <org_study_id>0127/11</org_study_id>
    <nct_id>NCT01693809</nct_id>
  </id_info>
  <brief_title>The Effects of Caffeine on Vestibular Evoked Myogenic Potentials in Healthy Subjects</brief_title>
  <official_title>The Effects of Caffeine on Vestibular Evoked Myogenic Potentials in Healthy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital do Servidor Publico Estadual</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital do Servidor Publico Estadual</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The principal aim of this study is to evaluate the presence of changes in cervical
      vestibular evoked myogenic potentials (VEMPc) after acute intake of caffeine in healthy
      subjects.

      Secondarily, it wants to standardize normal values ​​exam VEMPc in otorhinolaryngology
      service of the hospital.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">January 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Screening</study_design>
  <primary_outcome>
    <measure>Alteration of p13 and n23 latency and p13-n23 amplitude before and after caffeine intake.</measure>
    <time_frame>60 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>Caffeine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Caffeine 420mg, one time</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caffeine</intervention_name>
    <arm_group_label>Caffeine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy subjects

        Exclusion Criteria:

          -  hearing impairment

          -  caffeine abuse 24 hours before the test

          -  medication remains

          -  hypertension, dyslipidemia, diabetes mellitus or sleep disorders.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabio Akira Suzuki, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital do Servidor Publico Estadual</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana Maria Almeida Sousa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital do Servidor Publico Estadual</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital do Servidor Publico Estadual</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 29, 2012</lastchanged_date>
  <firstreceived_date>September 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital do Servidor Publico Estadual</investigator_affiliation>
    <investigator_full_name>Ana Maria Almeida de Sousa</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Caffeine</keyword>
  <keyword>Vestibular Evoked Myogenic Potentials</keyword>
  <keyword>dizziness</keyword>
  <keyword>vertigo</keyword>
  <keyword>tinnitus</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
